Cancer Care Grand Rounds
A new study suggests higher U.S. oncology spending is 'worth it.'
"A persistent health-care myth is that the U.S. system is uniquely wasteful versus the European countries that spend far less per patient as a result of tight government control. Only the establishment experts who spread this myth will be surprised, but new research shows American patients are often getting more value—better outcomes and longer lives—in return for those extra dollars."
No comments:
Post a Comment